Henry Schein celebrates new Southwestern Distribution Center
Henry Schein, Inc. recently marked the opening of an 811K-square-foot Southwestern Distribution Center in Fort Worth, Texas, the largest single building in the Company’s global network. Approximately 300 Team Schein Members, supplier partners, customers, elected officials, and Company leaders attended a ribbon-cutting ceremony to celebrate this significant milestone, which reinforces Henry Schein’s commitment to enhancing supply chain efficiency and customer service.
The new distribution center is 30% larger than the next biggest Henry Schein distribution center, and home to 255 Team Schein Members. The facility provides Team Schein with an even more efficient workspace to ensure health care professionals receive the products needed to deliver the best quality patient care.
“Our new Southwestern Distribution Center is a testament to Team Schein’s dedication to innovation, reliability, and customer service,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. “Over the course of our more than 90-year history, we have frequently reinvented the organization to meet customer needs, embracing new technologies and advancements. Our Fort Worth distribution center illustrates our commitment to holding fast to our enduring values while remaining focused on our future. We are pleased to begin this new chapter of our supply chain history in the Fort Worth community.”
Henry Schein has served its customers across the Southwest region for more than 20 years through its Grapevine, Texas, distribution center. The Company opened the doors of its 242,000 square foot Grapevine facility in 1998 with 66 Team Schein Members. During that time, the Company experienced tremendous growth, leading to the decision to find a larger space. More than 95 percent of Henry Schein’s Grapevine team relocated to the new facility in Fort Worth.
CME Corp. earns Worksite Health Award for a second year
CME Corp. was recently recognized with a Superior Worksite Health Award from Blue Cross & Blue Shield of Rhode Island (BCBSRI) and the Greater Providence Chamber of Commerce (the Chamber) for consistently implementing programs encouraging employee health and well-being in a meaningful way. In the last year CME Corp. has facilitated quarterly step challenges, two DietBet challenges, monthly BCBS Wellness Wednesday and Mindful Monday webinars, and monthly Employee Engagement activities focused on specific health/wellness/mindful topics.
“At CME Corp, we understand that to bring out the best in our employees, we must provide a healthy environment and foster a culture that values the well-being of each individual. By encouraging a balance between professional and personal life, we lay the foundation for our employees to thrive both in and out of the workplace,” said Maricar Caressimo, Chief Human Resources Officer.
FDA introduces online resources for reprocessing single-use medical devices
The FDA recently introduced online resources to provide information about reprocessing single-use medical devices for health care facilities and FAQs. The FDA remains dedicated to providing resources to help health care facilities establish, implement, or improve their quality assurance programs related to reprocessing single-use medical devices. The webpage provides information to help health care facilities understand the use of reprocessed medical devices originally labeled for single-use, and to clarify the level of FDA’s regulatory oversight of these reprocessed single-use medical devices to remain as safe and effective as the original manufactured devices.
The practice of reprocessing devices that are intended for single-use (known as single-use devices, SUDs) began in hospitals in the late 1970s. Since that time, this practice has become widespread as a mechanism to save costs for health care facilities and reduce medical waste. For example, use of reprocessed SUDs may reduce environmental impact by limiting the use of non-renewable resources and decreasing the amount of medical waste that requires treatment and disposal.
The FDA ensures the safety and effectiveness of reprocessed SUDs by regulating device manufacturers, third party reprocessors, and hospitals that reprocess SUDs in the same manner as the original equipment manufacturer (OEM).
Midmark introduces 2024-2025 Sterilizer Maintenance Kit Promotion
Midmark Corp., a leading medical solutions provider focused on the design of the clinical environment to improve the delivery of care, announced the 2024-2025 Sterilizer Maintenance Kit Promotion.
The next generation of Midmark steam sterilizers are designed for enhanced durability and workflow with integrated features to help care teams gain instrument processing and documentation compliance efficiencies. During the promotion, customers who purchase a next generation MidmarkM9 or M11 Steam Sterilizer and register the device will receive a free Sterilizer Maintenance Kit, valued up to $225. Each kit includes one door gasket, one dam gasket, one gasket ring and two mesh filters.
“Midmark’s next generation of steam sterilizers are designed to help make instrument processing as easy and automated as possible,” said Kurt Forsthoefel, marketing director, Midmark Medical. “The Sterilizer Maintenance Kit Promotion helps customers protect their investment. By registering the warranty, customers will receive prompt support when they need it and opt in to receive future notifications for available software updates.”
The promotion models include:
M11-050/-051
M9-050
To receive a free sterilizer maintenance kit, customers must purchase and register their device July 9, 2024–Apr. 30, 2025. For more information on the promotion, visit: midmark.com.
BD, Quest Diagnostics join forces to develop companion diagnostics for cancer, other diseases
BD and Quest Diagnostics announced a global collaboration agreement to develop, manufacture and commercialize flow cytometry-based companion diagnostics (CDx) intended to help select the best treatment for patients with cancer and other diseases.
Together, BD and Quest will aim to provide the pharmaceutical industry with an end-to-end solution for CDx development. The joint offerings will range from exploratory panel development to the manufacturing and distribution of FDA-approved diagnostic kits. sing companion diagnostics to help select a first-line therapy for cancer patients can be critical to ensuring the best outcomes and cost savings. Today’s companion diagnostic tests commonly involve technologies such as immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), polymerase chain reaction (PCR), next-generation sequencing (NGS) and imaging. Flow cytometry, an established laboratory technology now being applied in the development of companion diagnostics, can rapidly analyze and sort individual cells to enable health care providers to understand an individual’s immune response and could provide insight as to how best to manage the patient to improve clinical outcomes.
Owens & Minor, Inc. signs definitive agreement to acquire Rotech Healthcare Holdings, Inc.
Owens & Minor, Inc. announced that it has entered into a definitive agreement to acquire Rotech Healthcare Holdings, Inc. (“Rotech”), a privately held home based care business headquartered in Orlando, Florida, for $1.36 billion in cash. Given anticipated tax benefits of approximately $40 million from the transaction, the net purchase price is approximately $1.32 billion, which represents approximately a 6.3x multiple of LTM EBITDA, excluding synergies.
Rotech is a national leader in providing home medical equipment in the United States. The company has over 4,200 employees and provides products and services in 46 states through approximately 325 operating locations. Rotech generated approximately $750 million of revenue and an EBITDA margin of nearly 30% in 2023.